Found: 36
Select item for more details and to access through your institution.
The role of <sup>18</sup>F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4241, doi. 10.1007/s00259-022-05872-z
- By:
- Publication type:
- Article
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the EANM perspective.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The era of prostate-specific membrane antigen (PSMA)–based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Correction to: Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Shining new light on lung cancer diagnosis using a pafolacianine molecular tracer.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Evaluation of pediatric malignancies using total-body PET/CT with half-dose [<sup>18</sup>F]-FDG.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4145, doi. 10.1007/s00259-022-05893-8
- By:
- Publication type:
- Article
The optimal <sup>18</sup>F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO<sub>2</sub> electron paramagnetic resonance imaging as reference truth.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4014, doi. 10.1007/s00259-022-05889-4
- By:
- Publication type:
- Article
Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4156, doi. 10.1007/s00259-022-05886-7
- By:
- Publication type:
- Article
PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [<sup>68</sup>Ga]Ga-PSMA-617.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4000, doi. 10.1007/s00259-022-05884-9
- By:
- Publication type:
- Article
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with <sup>177</sup>Lu-PSMA I&T therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4064, doi. 10.1007/s00259-022-05883-w
- By:
- Publication type:
- Article
[<sup>64</sup>Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4271, doi. 10.1007/s00259-022-05882-x
- By:
- Publication type:
- Article
Targeted detection of cancer cells during biopsy allows real-time diagnosis of pulmonary nodules.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4194, doi. 10.1007/s00259-022-05868-9
- By:
- Publication type:
- Article
A first-in-human study of [<sup>68</sup>Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4037, doi. 10.1007/s00259-022-05880-z
- By:
- Publication type:
- Article
Predicting response of micrometastases with MIRDcell V3: proof of principle with <sup>225</sup>Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 3989, doi. 10.1007/s00259-022-05878-7
- By:
- Publication type:
- Article
Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Diagnostic performance of [<sup>18</sup>F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4205, doi. 10.1007/s00259-022-05871-0
- By:
- Publication type:
- Article
Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4048, doi. 10.1007/s00259-022-05867-w
- By:
- Publication type:
- Article
Reproducibility of quantitative coronary calcium scoring from PET/CT attenuation maps: comparison to ECG-gated CT scans.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4122, doi. 10.1007/s00259-022-05866-x
- By:
- Publication type:
- Article
Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4171, doi. 10.1007/s00259-022-05865-y
- By:
- Publication type:
- Article
Primary biphasic synovial sarcoma of the liver with multiple bone metastases detected by PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4284, doi. 10.1007/s00259-022-05863-0
- By:
- Publication type:
- Article
PET/CT imaging of CSF1R in a mouse model of tuberculosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4088, doi. 10.1007/s00259-022-05862-1
- By:
- Publication type:
- Article
Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with <sup>223</sup>Ra.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 3981, doi. 10.1007/s00259-022-05860-3
- By:
- Publication type:
- Article
Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4073, doi. 10.1007/s00259-022-05854-1
- By:
- Publication type:
- Article
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4262, doi. 10.1007/s00259-022-05853-2
- By:
- Publication type:
- Article
A prospective head-to-head comparison of <sup>68</sup> Ga-NOTA-3P-TATE-RGD and <sup>68</sup> Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4218, doi. 10.1007/s00259-022-05852-3
- By:
- Publication type:
- Article
Improving the imaging diagnostic strategy for pulmonary artery masses based on <sup>18</sup>F-FDG PET/CT integrated with CTPA.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4109, doi. 10.1007/s00259-022-05851-4
- By:
- Publication type:
- Article
CXCR4-targeted theranostics in oncology.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4133, doi. 10.1007/s00259-022-05849-y
- By:
- Publication type:
- Article
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4182, doi. 10.1007/s00259-022-05848-z
- By:
- Publication type:
- Article
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4228, doi. 10.1007/s00259-022-05847-0
- By:
- Publication type:
- Article
A comparison of advanced semi-quantitative amyloid PET analysis methods.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4097, doi. 10.1007/s00259-022-05846-1
- By:
- Publication type:
- Article
Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Preclinical evaluation and pilot clinical study of [<sup>18</sup>F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4025, doi. 10.1007/s00259-022-05836-3
- By:
- Publication type:
- Article
Comparing the clinical performance and cost efficacy of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4252, doi. 10.1007/s00259-021-05620-9
- By:
- Publication type:
- Article